Global Cancer Biomarkers Market
The global Cancer Biomarkers Market was valued at USD 10.19 billion in 2016 and is projected to reach USD 28.03 billion by 2025, growing at a CAGR of 11.9% from 2017 to 2025.
Cancer Biomarkers have high usage in Cancer diagnostics and treatment, especially in Tissue specific therapies. Therefore market of this genetically engineered product is seeing high values in terms of market value.
1. Market Drivers
1.1 Increasing Technological Developments
1.2 Growingnumber of cancer Patients and usage of biomarkers
1.3 Increasing research in biomarkers
2. Market Restraints
2.1 Reimbursements Risks
2.2 High investment and uncertainty of favorable profits
2.3 Technicality concerns
1. Global Cancer Biomarkers Market, by Application:
1.2 Research and Development
1.4 Risk Assessment
1.5 Other Applications
2. Global Cancer Biomarkers Market, by Cancer Type:
2.1 Breast Cancer
2.2 Lung Cancer
2.3 Colorectal Cancer
2.4 Prostate Cancer
2.5 Non-Hodgkinâ€™s Lymphoma
2.8 Thyroid Cancer
2.9 Bladder Cancer
2.10 Kidney Cance
2.11 Other Cancer Types
3. Global Cancer Biomarkers Market, by Profiling Technology:
3.1 Omics Technologies
184.108.40.206 Next-Generation Sequencing (NGS)
220.127.116.11 Polymerase Chain Reaction (PCR)
3.1.3 Other Omics Technologies
3.2 Imaging Technologies
3.2.2 Computed Tomography (Ct)
3.2.3 Magnetic Resonance Imaging (Mri)
3.2.4 Positron Emission Tomography (Pet)
3.4.1 in Situ Hybridization (Ish)
3.4.2 Other Cytogenetics-Based Tests
4. Global Cancer Biomarkers Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
The major players in the market are as follows:
1. Thermo Fisher Scientific
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Qiagen N.V.
6. GE Healthcare
7. Agilent Technologies
8. BiomÃ©rieux SA
9. Merck & Co.
10. Abbott Laboratories
11. Becton, Dickinson and Company
12. Danaher Corporation
13. Myriad Genetics
14. Sysmex Corporation
16. Quest Diagnostics
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cancer Biomarkers Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.